rcca-header
Clinical Trials

An Open-Label, Dose-Finding, and Cohort-Expansion Phase 1 Study Evaluating Safety and Efficacy of INCB050465 in Combination with Bendamustine and Obinutuzumab in Subjects With Relapsed or Refractory Follicular Lymphoma

Type of Cancer
Lymphoma
Phase
Division (Location)
Bethesda, MD
Study ID
NCT#
Brief Description
An Open-Label, Dose-Finding, and Cohort-Expansion Phase 1 Study Evaluating Safety and Efficacy of INCB050465 in Combination with Bendamustine and Obinutuzumab in Subjects With Relapsed or Refractory Follicular Lymphoma

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.